Laurus Labs Stock

Laurus Labs Equity

The The Equity of Laurus Labs (LAURUSLABS.NS) as of Aug 12, 2026 is 44.73 B INR. In the previous year, The Equity was 41.11 B INR — a change of 8.80% (higher).

Equity

44.73 BINR

YoY

8.80%

Last updated:

In 2026, Laurus Labs's equity was 44.73 B INR, a 8.80% increase from the 41.11 B INR equity in the previous year.

Access this data via the Eulerpool API

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Laurus Labs's Equity

Laurus Labs's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Laurus Labs's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Laurus Labs's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Laurus Labs's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Laurus Labs’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Laurus Labs stock

The Equity of Laurus Labs is 44.73 B INR in 2026.

The Equity of Laurus Labs changed from 41.11 B INR to 44.73 B INR, representing a 8.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Laurus Labs historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Laurus Labs

All Key Metrics — Laurus Labs